Semaglutide use linked to ischaemic optic neuropathy
Increased risk for seen with semaglutide versus non-GLP-1 receptor agonist diabetes medications.
Semaglutide is associated with non-arteritic anterior ischaemic optic neuropathy among patients with type 2 diabetes and those with overweight or obesity, according to a US study in JAMA Ophthalmology.
Harvard University-led researchers examined the potential association between semaglutide (Ozempic and Wegovy) and the risk for non-arteritic anterior ischaemic optic neuropathy (NAION) in a retrospective matched cohort study.
